Anastrozole-induced subacute cutaneous lupus erythematosus [3]

British Journal of Dermatology

Volumn 158, Issue 3, 2008, Pages 628-629

  Trancart, M ^a   Cavailhes, A ^a   Balme, B ^b   Skowron, F ^a  

^a CENTRE HOSPITALIER DE VALENCE   (France)

^b HÔTEL DIEU   (France)

Author keywords

Anastrozole; Breast cancer; Drug induced; Subacute cutaneous lupus erythematosus; Third generation aromatase inhibitors

Indexed keywords

ANASTROZOLE; ATENOLOL; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOUBLE STRANDED DNA ANTIBODY; HISTONE ANTIBODY; HYDROXYCHLOROQUINE; RO ANTIBODY;

AGED; BREAST CANCER; BURNING SENSATION; CASE REPORT; DRUG ERUPTION; DRUG RECHALLENGE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HISTOPATHOLOGY; HUMAN; HYPERTENSION; LETTER; PRIORITY JOURNAL; PRURITUS; SKIN BIOPSY; SKIN LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

AGED; ANTINEOPLASTIC AGENTS, HORMONAL; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, CUTANEOUS; NITRILES; TREATMENT OUTCOME; TRIAZOLES;

EID: 39049085295     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2007.08367.x     Document Type: Letter

References (9)

1. Sontheimer RD, Thomas JR, Gilliam JN. Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979 115 : 1409 15.
2. Goodfield MJD, Jones SK, Veale DJ. The 'connective tissue diseases'. In : Rook's Textbook of Dermatology (Burns T, Breathnach SM, Cox NH, Griffiths CEM, eds 7th edn, Vol. 3. Oxford : Blackwell Publishing, 2004 56 : 24 8.
3. Srivastava M, Rencic A, Diglio G et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003 139 : 45 9.
4. Sarzi-Puttini P, Atzeni F, Capsoni F et al. Drug-induced lupus erythematosus. Autoimmunity 2005 38 : 507 18.
5. Grana G. Adjuvant aromatase inhibitor therapy for early breast cancer: a review of the most recent data. J Surg Oncol 2006 93 : 585 92.
6. Buzdar AU. Data from the Arimidex, tamoxifen, alone or in combination (ATAC) trial: implications for use of aromatase inhibitors in 2003. Clin Cancer Res 2004 10 : S355 61.
7. Sthoeger ZM, Zinger H, Mozes E. Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZB x NZW) F1 female mice are associated with specific reduction of IgG3 autoantibodies. Ann Rheum Dis 2003 62 : 341 6.
8. Dayan M, Zinger H, Kalush F et al. The beneficial effects of treatment with tamoxifen and anti-oestradiol antibody on experimental systemic lupus erythematosus are associated with cytokine modulations. Immunology 1997 90 : 101 8.
9. Fumal I, Danchin A, Cosserat F et al. Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases. Dermatology 2005 210 : 251 2.